Get started
Author

Taisuke Kikuchi

Observed names: TAISUKE KIKUCHI, Taisuke KIKUCHI
OpenAlex ID: A5102094824
Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus
2006 · Christine Guo, Diego Martinez-Vasquez, et al. · Endocrinology · 174
Aldosterone Stimulates Gene Expression of Hepatic Gluconeogenic Enzymes through the Glucocorticoid Receptor in a Manner Independent of the Protein Kinase B Cascade
2004 · Ryo YAMASHITA, Taisuke KIKUCHI, et al. · Endocrine Journal · 55
PDF
Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study
2015 · Takashi Iizuka, Kotaro Iemitsu, et al. · Journal of Clinical Medicine Research · 39
PDF
Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study
2016 · Kotaro Iemitsu, Takashi Iizuka, et al. · Journal of Clinical Medicine Research · 36
PDF
Canagliflozin Increases Calorie Intake in Type 2 Diabetes Without Changing the Energy Ratio of the Three Macronutrients: CANA-K Study
2020 · Ikuro Matsuba, Akira Kanamori, et al. · Diabetes Technology & Therapeutics · 33
Correlations of Fasting and Postprandial Blood Glucose Increments to the Overall Diurnal Hyperglycemic Status in Type 2 Diabetic Patients: Variations with Levels of HbA1c
2010 · Kaori KIKUCHI, Uru NEZU, et al. · Endocrine Journal · 31
PDF
The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH
2004 · Jun-Ichi Togawa, Tomoo Takamura, et al. · Journal of Gastroenterology · 29
Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?
2005 · Masahiko Inamori, Jun-Ichi Togawa, et al. · Journal of Gastroenterology · 25
Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus
2017 · Takehiro Kawata, Takashi Iizuka, et al. · Journal of Clinical Medicine Research · 24
PDF
Dehydroepiandrosterone Suppresses Elevated Hepatic Glucose-6-phosphatase mRNA Level in C57BL/KsJ-db/db Mice. Comparison with Troglitazone.
2000 · KAZUTAKA AOKI, TAISUKE KIKUCHI, et al. · Endocrine Journal · 22
PDF
Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: Which is suitable for on‐demand therapy?
2003 · MASAHIKO INAMORI, JUN‐ICHI TOGAWA, et al. · Journal of Gastroenterology and Hepatology · 16
Effects of 1‐year treatment with canagliflozin on body composition and total body water in patients with type 2 diabetes
2021 · Ikuro Matsuba, Masahiro Takihata, et al. · Diabetes Obesity and Metabolism · 14
Efficacy and Safety of Ipragliflozin in Patients With Type 2 Diabetes: ASSIGN-K Study
2019 · Kotaro Iemitsu, Takehiro Kawata, et al. · Journal of Endocrinology and Metabolism · 4
PDF
Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study
2017 · Kotaro Iemitsu, Takehiro Kawata, et al. · Journal of Clinical Medicine Research · 4
PDF
Evaluation of the effects of anti-secretory drugs on intragastric acidity: is combined therapy with a proton pump inhibitor and an H2 receptor antagonist effective as initial treatment?
2005 · Masahiko Inamori, Jun-ichi Togawa, et al. · Journal of Gastroenterology · 4
Sitagliptin Versus Ipragliflozin for Type 2 Diabetes in Clinical Practice
2019 · Ikuro Matsuba, Kotaro Iemitsu, et al. · Journal of Endocrinology and Metabolism · 2
PDF
Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study
2016 · Takashi Iizuka, Kotaro Iemitsu, et al. · Journal of Clinical Medicine Research · 1
PDF
Author response for "Effects of 1‐year treatment with canagliflozin on body composition and total body water in patients with type 2 diabetes"
2021 · Ikuro Matsuba, Masahiro Takihata, et al. · Publons reviews and discussion
Works count: 18
Citation count: 513
H-index: 12
I10-index: 12
Year
Topic
Type